Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: augmented reality

In today’s AI news, OpenAI will ship GPT-5 in a matter of months and streamline its AI models into more unified products, said CEO Sam Altman in an update. Specifically, Altman says the company plans to launch GPT-4.5 as its last non-chain-of-thought model and integrate its latest o3 reasoning model into GPT-5.

In other advancements, Harvey, a San Francisco AI startup focused on the legal industry, has raised $300 million in a funding round led by Sequoia that values the startup at $3 billion — double the amount investors valued it at in July. The Series D funding round builds on the momentum and reflects investors’ enthusiasm for AI tools …

Meanwhile, Meta is in talks to acquire South Korean AI chip startup FuriosaAI, according to people familiar with the matter, a deal that could boost the social media giant’s custom chip efforts amid a shortage of Nvidia chips and a growing demand for alternatives. The deal could be completed as early as this month.

Then, AI took another step into Hollywood today with the launch of a new filmmaking tool from showbiz startup Flawless. The product — named DeepEditor — promises cinematic wizardry for the digital age. For movie makers, the tool offers photorealistic edits without a costly return to set.

In videos, join IBM’s Boris Sobolev as he explains how model customization can enhance reliability and decision-making of agentic systems. Discover practical tips for data collection, tool use, and pushing the boundaries of what your AI can achieve. Supercharge your AI agents for peak performance!

Continue reading “Sam Altman Announces GPT-5 Timeline Update, Cancels o3 As Standalone Model” | >

Researchers at the University of Liège (Belgium) have uncovered a previously unknown mechanism that regulates the immune response against parasites. During a parasitic infection, specific immune cells, known as virtual memory T cells, become activated and express a surface molecule called CD22, which prevents an excessive immune reaction. This discovery could help in better-controlling inflammation and improving immune responses to infections.

The findings are published in the journal Science Immunology.

Nearly a quarter of the world’s population is infected by helminths, that establish themselves in the intestine for extended periods. In response to these invaders, the immune system deploys complex defense strategies. In their recent study, the researchers revealed a previously unsuspected mechanism that regulates the activation of certain : CD8+ virtual memory T cells (TVM).

Read more | >

A research team at POSTECH has developed a novel multidimensional sampling theory to overcome the limitations of flat optics. Their study not only identifies the constraints of conventional sampling theories in metasurface design but also presents an innovative anti-aliasing strategy that significantly enhances optical performance. Their findings were published in Nature Communications.

Flat optics is a cutting-edge technology that manipulates light at the nanoscale by patterning ultra-thin surfaces with nanostructures. Unlike traditional optical systems that rely on bulky lenses and mirrors, enables ultra-compact, high-performance optical devices. This innovation is particularly crucial in miniaturizing smartphone cameras (reducing the “camera bump”) and advancing AR/VR technologies.

Metasurfaces, one of the most promising applications of flat optics, rely on hundreds of millions of nanostructures to precisely sample and control the phase distribution of light. Sampling, in this context, refers to the process of converting analog optical signals into discrete data points—similar to how the human brain processes visual information by rapidly capturing multiple images per second to create continuous motion perception.

Read more | >

Join me as I explore the most incredible innovations at CES 2025! As a Las Vegas local and tech enthusiast, I’ve found the coolest, most unexpected tech that’s shaping our future. From AI companions to flying cars, this year’s show was packed with amazing discoveries.

🎯 Featured in this video:
NVIDIA’s Groundbreaking AI Keynote.
Rokid AR Glasses with Real-Time Translation.
Holobox Mini Holographic Display.
Toshiba REGZA AI TV
Ropet AI Companion.
Code 27 Digital Character Display.
Sirius Dog.
Unitree Robotics.
Aotos Rideable Suitcase.
InMotion Electric Unicycle.
Xpeng Flying Car.
Waymo Zeekr RT Autonomous Vehicle.
🔥 Highlights:
Cutting-edge AI demonstrations.
Real-time language translation.
Next-gen holographic displays.
Advanced robotics.
Interactive AI companions.
Revolutionary personal transportation.
Smart home innovations.
And much more!

👋 Connect with me:
Instagram: @VegasNavigator.
Website: VegasNavigator.com.

#CES2025 #Technology #LasVegas #TechReview #Innovation #AI #FutureTech #VegasNavigator

Continue reading “CES 2025 : The Craziest Tech I Found” | >

NVIDIA has filed a patent for augmented reality (AR) glasses. These glasses may look like regular glasses but with some special features on the inside. It also appears that the company is looking to make these glasses lightweight and energy-efficient while offering high-quality visuals.

The patent titled “Backlight-Free Augmented Reality Digital Holography” can be found under the number 20250004275A1 on the United States Patent and Trademark Office (USPTO) website. Thanks to SETI Park, an independent patent researcher, for sharing its details on X.

Read more | >

Xreal is making waves in the world of mixed reality technology, offering a unique approach with its lightweight, almost portable glasses that project virtual screens directly in front of users’ eyes. The latest models, Xreal One and One Pro, come with a game-changing feature that enhances their usability—plug-and-play compatibility with nearly any device equipped with a USB-C video output.

Unlike previous models like the Air 2 Ultra, the Xreal One and One Pro are focused purely on screen mirroring. The glasses can seamlessly display content from an extensive range of devices, including iPhones, Android smartphones, Macs, PCs, and even the Steam Deck. All it takes is a quick connection via USB-C, and you’ll have a massive virtual screen in front of you—perfect for work, gaming, or watching a movie.

The technology behind these glasses relies on micro-OLED displays made by Sony, offering a resolution of 1920 × 1080 per eye. While this doesn’t quite match the ultra-high resolution of Apple’s Vision Pro, it’s worth noting that Xreal’s glasses come at a fraction of the cost—nearly ten times cheaper, in fact.

Read more | >

For those unaware, Whisk3D (original name Blendersito) is Dante’s Symbian-powered version of Blender, which he has been developing since late 2022. The app allows users to upload and model 3D characters on the phone, design game level assets, extrude vertices and edges, create planes, and even connect the phone to a monitor and keyboard for more convenient use.

In a true Blender fashion, Dante’s Whisk3D is open-source and can be accessed via the creator’s GitHub page. You can also support Dante here and check out more jaw-dropping experiments with Nokia-ran Blender over here.

Read more | >

Published in Nature Communications, a new study led by the University of Minnesota Medical School and Duke University found that a DNA sequencing test for advanced prostate cancer patients can distinguish between patients with poor and favorable prognoses.

The new blood-based —called AR-ctDETECT—is designed to detect and analyze small fragments of tumor-derived DNA in the blood of certain with advanced, .

In this new study, the AR-ctDETECT test was used to analyze DNA from more than 770 from a phase 3 clinical trial of advanced prostate cancer patients. The test identified circulating tumor DNA (ctDNA) in 59% of patients with metastatic prostate cancer. Patients with detectable circulating tumor DNA had significantly worse overall survival compared to those without. These results demonstrate the potential of the AR-ctDETECT test to provide key genetic information to tailor treatments based on similar characteristics among patients.

Read more | >